{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:56:51Z","timestamp":1794333411984,"version":"4.9.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001511","name":"Auckland Medical Research Foundation","doi-asserted-by":"publisher","award":["1417003"],"award-info":[{"award-number":["1417003"]}],"id":[{"id":"10.13039\/501100001511","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD091075"],"award-info":[{"award-number":["R01HD091075"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Neonatal hypoglycaemia is a common but treatable metabolic disorder that affects newborn infants and which, if not identified and treated adequately, may result in neurological sequelae that persist for the lifetime of the patient. The long-term financial and quality-of-life burden of neonatal hypoglycaemia has not been previously examined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We assessed the postnatal hospital and long-term costs associated with neonatal hypoglycaemia over 80\u2009year and 18\u2009year time horizons, using a health-system perspective and assessing impact on quality of life using quality-adjusted life year (QALYs). A decision analytic model was used to represent key outcomes in the presence and absence of neonatal hypoglycaemia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The chance of developing one of the outcomes of neonatal hypoglycaemia in our model (cerebral palsy, learning disabilities, seizures, vision disorders) was 24.03% in subjects who experienced neonatal hypoglycaemia and 3.56% in those who do did not.<\/jats:p><jats:p>Over an 80\u2009year time horizon a subject who experienced neonatal hypoglycaemia had a combined hospital and post-discharge cost of NZ$72,000 due to the outcomes modelled, which is NZ$66,000 greater than a subject without neonatal hypoglycaemia. The net monetary benefit lost due to neonatal hypoglycaemia, using a value per QALY of NZ$43,000, is NZ$180,000 over an 80\u2009year time horizon.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Even under the most conservative of estimates, neonatal hypoglycaemia contributes a significant financial burden to the health system both during childhood and over a lifetime. The combination of direct costs and loss of quality of life due to neonatal hypoglycaemia means that this condition warrants further research to focus on prevention and effective treatment.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12913-021-06098-9","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T11:08:26Z","timestamp":1612523306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cost burden and net monetary benefit loss of neonatal hypoglycaemia"],"prefix":"10.1186","volume":"21","author":[{"given":"Matthew J.","family":"Glasgow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Edlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2697-1422","authenticated-orcid":false,"given":"Jane E.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"6098_CR1","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/bmj.297.6659.1304","volume":"297","author":"A Lucas","year":"1988","unstructured":"Lucas A, Morley R, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. BMJ. 1988;297:1304\u20138.","journal-title":"BMJ"},{"key":"6098_CR2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jpeds.2012.05.022","volume":"161","author":"DL Harris","year":"2012","unstructured":"Harris DL, Weston PJ, Harding JE. Incidence of neonatal hypoglycemia in babies identified as at risk. J Pediatr. 2012;161:787\u201391.","journal-title":"J Pediatr"},{"key":"6098_CR3","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jpeds.2009.06.044","volume":"155","author":"WW Hay Jr","year":"2009","unstructured":"Hay WW Jr, Raju TN, Higgins RD, Kalhan SC, Devaskar SU. Knowledge gaps and research needs for understanding and treating neonatal hypoglycemia: workshop report from Eunice Kennedy Shriver National Institute of Child Health and Human Development. J Pediatr. 2009;155:612\u20137.","journal-title":"J Pediatr"},{"key":"6098_CR4","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1542\/peds.85.5.834","volume":"85","author":"M Cornblath","year":"1990","unstructured":"Cornblath M, Schwartz R, Aynsley-Green A, Lloyd JK. Hypoglycemia in infancy: the need for a rational definition. A Ciba Foundation discussion meeting. Pediatrics. 1990;85:834\u20137.","journal-title":"Pediatrics"},{"key":"6098_CR5","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1542\/peds.2005-1919","volume":"117","author":"N Boluyt","year":"2006","unstructured":"Boluyt N, van Kempen A, Offringa M. Neurodevelopment after neonatal hypoglycemia: a systematic review and design of an optimal future study. Pediatrics. 2006;117:2231\u201343.","journal-title":"Pediatrics"},{"key":"6098_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jpeds.2018.02.036","volume":"198","author":"MJ Glasgow","year":"2018","unstructured":"Glasgow MJ, Harding JE, Edlin R. Cost analysis of treating neonatal hypoglycemia with dextrose gel. J Pediatr. 2018;198:151\u20135.","journal-title":"J Pediatr"},{"key":"6098_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.earlhumdev.2016.12.009","volume":"104","author":"JE Harding","year":"2017","unstructured":"Harding JE, Harris DL, Hegarty JE, Alsweiler JM, McKinlay CJ. An emerging evidence base for the management of neonatal hypoglycaemia. Early Hum Dev. 2017;104:51\u20136.","journal-title":"Early Hum Dev"},{"key":"6098_CR8","unstructured":"New Zealand health system. New Zealand Ministry of Health, 2018. at https:\/\/www.health.govt.nz\/new-zealand-health-system.)"},{"key":"6098_CR9","first-page":"5","volume":"54","author":"R Pildes","year":"1974","unstructured":"Pildes R, Cornblath M, Warren I, et al. A prospective controlled study of neonatal hypoglycemia. Pediatrics. 1974;54:5\u201314.","journal-title":"Pediatrics"},{"issue":"Pt 4","key":"6098_CR10","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1093\/brain\/119.4.1277","volume":"119","author":"RJ McCrimmon","year":"1996","unstructured":"McCrimmon RJ, Deary IJ, Huntly BJ, MacLeod KJ, Frier BM. Visual information processing during controlled hypoglycaemia in humans. Brain. 1996;119(Pt 4):1277\u201387.","journal-title":"Brain"},{"key":"6098_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0022-3476(99)70209-X","volume":"134","author":"CB Duvanel","year":"1999","unstructured":"Duvanel CB, Fawer CL, Cotting J, Hohlfeld P, Matthieu JM. Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-for-gestational-age preterm infants. J Pediatr. 1999;134:492\u20138.","journal-title":"J Pediatr"},{"key":"6098_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1542\/peds.2007-2822","volume":"122","author":"CM Burns","year":"2008","unstructured":"Burns CM, Rutherford MA, Boardman JP, Cowan FM. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics. 2008;122:65\u201374.","journal-title":"Pediatrics"},{"key":"6098_CR13","doi-asserted-by":"publisher","first-page":"F94","DOI":"10.1136\/fn.79.2.F94","volume":"79","author":"A Ornoy","year":"1998","unstructured":"Ornoy A, Ratzon N, Greenbaum C, Peretz E, Soriano D, Dulitzky M. Neurobehaviour of school age children born to diabetic mothers. Arch Dis Child Fetal Neonatal Ed. 1998;79:F94\u20139.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"Suppl 1","key":"6098_CR14","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1007\/PL00014319","volume":"158","author":"JM Hawdon","year":"1999","unstructured":"Hawdon JM. Hypoglycaemia and the neonatal brain. Eur J Pediatr. 1999;158(Suppl 1):S9\u2013S12.","journal-title":"Eur J Pediatr"},{"key":"6098_CR15","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1037\/0735-7044.114.5.950","volume":"114","author":"CA Nelson","year":"2000","unstructured":"Nelson CA, Wewerka S, Thomas KM, Tribby-Walbridge S, deRegnier R, Georgieff M. Neurocognitive sequelae of infants of diabetic mothers. Behav Neurosci. 2000;114:950\u20136.","journal-title":"Behav Neurosci"},{"key":"6098_CR16","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1093\/brain\/awh618","volume":"128","author":"LJ Woodward","year":"2005","unstructured":"Woodward LJ, Edgin JO, Thompson D, Inder TE. Object working memory deficits predicted by early brain injury and development in the preterm infant. Brain. 2005;128:2578\u201387.","journal-title":"Brain"},{"key":"6098_CR17","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1093\/brain\/awn227","volume":"131","author":"MH Beauchamp","year":"2008","unstructured":"Beauchamp MH, Thompson DK, Howard K, et al. Preterm infant hippocampal volumes correlate with later working memory deficits. Brain. 2008;131:2986\u201394.","journal-title":"Brain"},{"key":"6098_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1017\/S0012162205001039","volume":"47","author":"T DeBoer","year":"2005","unstructured":"DeBoer T, Wewerka S, Bauer PJ, Georgieff MK, Nelson CA. Explicit memory performance in infants of diabetic mothers at 1 year of age. Dev Med Child Neurol. 2005;47:525\u201331.","journal-title":"Dev Med Child Neurol"},{"key":"6098_CR19","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jpeds.2005.11.015","volume":"148","author":"PM Filan","year":"2006","unstructured":"Filan PM, Inder TE, Cameron FJ, Kean MJ, Hunt RW. Neonatal hypoglycemia and occipital cerebral injury. J Pediatr. 2006;148:552\u20135.","journal-title":"J Pediatr"},{"key":"6098_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1542\/peds.2007-2002","volume":"122","author":"EW Tam","year":"2008","unstructured":"Tam EW, Widjaja E, Blaser SI, Macgregor DL, Satodia P, Moore AM. Occipital lobe injury and cortical visual outcomes after neonatal hypoglycemia. Pediatrics. 2008;122:507\u201312.","journal-title":"Pediatrics"},{"key":"6098_CR21","first-page":"127","volume":"46","author":"V Udani","year":"2009","unstructured":"Udani V, Munot P, Ursekar M, Gupta S. Neonatal hypoglycemic brain - injury a common cause of infantile onset remote symptomatic epilepsy. Indian Pediatr. 2009;46:127\u201332.","journal-title":"Indian Pediatr"},{"key":"6098_CR22","unstructured":"Checklist for Prevalence Studies. University of Adelaide, 2016. at http:\/\/joannabriggs-webdev.org\/assets\/docs\/critical-appraisal-tools\/JBI_Critical_Appraisal-Checklist_for_Prevalence_Studies.pdf.)"},{"key":"6098_CR23","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/jamapediatrics.2017.1579","volume":"171","author":"C McKinlay","year":"2017","unstructured":"McKinlay C, Alsweiler J, Anstice N, et al. Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years. JAMA Pediatr. 2017;171:972\u201383.","journal-title":"JAMA Pediatr"},{"key":"6098_CR24","doi-asserted-by":"publisher","first-page":"e1497","DOI":"10.1542\/peds.2012-0776","volume":"130","author":"W Tin","year":"2012","unstructured":"Tin W, Brunskill G, Kelly T, Fritz S. 15-year follow-up of recurrent \"hypoglycemia\" in preterm infants. Pediatrics. 2012;130:e1497\u2013503.","journal-title":"Pediatrics"},{"key":"6098_CR25","doi-asserted-by":"crossref","unstructured":"Goode RH, Rettiganti M, Li J, et al. Developmental outcomes of preterm infants with neonatal hypoglycemia. Pediatrics. 2016;138.","DOI":"10.1542\/peds.2016-1424"},{"key":"6098_CR26","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/jamapediatrics.2015.1631","volume":"169","author":"JR Kaiser","year":"2015","unstructured":"Kaiser JR, Bai S, Gibson N, et al. Association between transient newborn hypoglycemia and fourth-grade achievement test proficiency: a population-based study. JAMA Pediatr. 2015;169:913\u201321.","journal-title":"JAMA Pediatr"},{"key":"6098_CR27","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1542\/peds.2012-0079","volume":"130","author":"JM Kerstjens","year":"2012","unstructured":"Kerstjens JM, Bocca-Tjeertes IF, de Winter AF, Reijneveld SA, Bos AF. Neonatal morbidities and developmental delay in moderately preterm-born children. Pediatrics. 2012;130:e265\u201372.","journal-title":"Pediatrics"},{"key":"6098_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jpeds.2017.05.052","volume":"188","author":"AC Tottman","year":"2017","unstructured":"Tottman AC, Alsweiler JM, Bloomfield FH, Pan M, Harding JE. Relationship between measures of neonatal glycemia, neonatal illness, and 2-year outcomes in very preterm infants. J Pediatr. 2017;188:115\u201321.","journal-title":"J Pediatr"},{"key":"6098_CR29","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1001\/jamaneurol.2016.6130","volume":"74","author":"N Razaz","year":"2017","unstructured":"Razaz N, Tedroff K, Villamor E, Cnattingius S. Maternal body mass index in early pregnancy and risk of epilepsy in offspring. JAMA Neurol. 2017;74:668\u201376.","journal-title":"JAMA Neurol"},{"key":"6098_CR30","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1504909","volume":"373","author":"C McKinlay","year":"2015","unstructured":"McKinlay C, Alsweiler J, Ansell J, et al. Neonatal glycemia and neurodevelopmental outcomes at 2 years. N Engl J Med. 2015;373:1507\u201318.","journal-title":"N Engl J Med"},{"key":"6098_CR31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jpeds.2015.10.066","volume":"170","author":"DL Harris","year":"2016","unstructured":"Harris DL, Alsweiler JM, Ansell JM, et al. Outcome at 2 years after dextrose gel treatment for neonatal hypoglycemia: follow-up of a randomized trial. J Pediatr. 2016;170:54\u20139 e2.","journal-title":"J Pediatr"},{"key":"6098_CR32","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/dmcn.12080","volume":"55","author":"M Oskoui","year":"2013","unstructured":"Oskoui M, Coutinho F, Dykeman J, Jette N, Pringsheim T. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev Med Child Neurol. 2013;55:509\u201319.","journal-title":"Dev Med Child Neurol"},{"key":"6098_CR33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","volume":"88","author":"KM Fiest","year":"2017","unstructured":"Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology. 2017;88:296\u2013303.","journal-title":"Neurology"},{"key":"6098_CR34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ridd.2010.12.018","volume":"32","author":"PK Maulik","year":"2011","unstructured":"Maulik PK, Mascarenhas MN, Mathers CD, Dua T, Saxena S. Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil. 2011;32:419\u201336.","journal-title":"Res Dev Disabil"},{"key":"6098_CR35","doi-asserted-by":"publisher","first-page":"e888","DOI":"10.1016\/S2214-109X(17)30293-0","volume":"5","author":"RRA Bourne","year":"2017","unstructured":"Bourne RRA, Flaxman SR, Braithwaite T, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e888\u2013e97.","journal-title":"Lancet Glob Health"},{"key":"6098_CR36","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ridd.2011.12.001","volume":"33","author":"V Kancherla","year":"2012","unstructured":"Kancherla V, Amendah DD, Grosse SD, Yeargin-Allsopp M, Van Naarden Braun K. Medical expenditures attributable to cerebral palsy and intellectual disability among Medicaid-enrolled children. Res Dev Disabil. 2012;33:832\u201340.","journal-title":"Res Dev Disabil"},{"key":"6098_CR37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3109\/13668250.2011.648609","volume":"37","author":"CM Doran","year":"2012","unstructured":"Doran CM, Einfeld SL, Madden RH, et al. How much does intellectual disability really cost? First estimates for Australia. J Intellect Develop Disabil. 2012;37:42\u20139.","journal-title":"J Intellect Develop Disabil"},{"key":"6098_CR38","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1046\/j.1528-1157.2001.18200.x","volume":"42","author":"IA Kotsopoulos","year":"2001","unstructured":"Kotsopoulos IA, Evers SM, Ament AJ, de Krom MC. Estimating the costs of epilepsy: an international comparison of epilepsy cost studies. Epilepsia. 2001;42:634\u201340.","journal-title":"Epilepsia"},{"key":"6098_CR39","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/archophthalmol.2009.242","volume":"127","author":"JE Keeffe","year":"2009","unstructured":"Keeffe JE, Chou S-L, Lamoureux EL. The cost of care for people with impaired vision in Australia. Arch Ophthalmol-Chic. 2009;127:1377\u201381.","journal-title":"Arch Ophthalmol-Chic"},{"key":"6098_CR40","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/bjo.2005.080986","volume":"90","author":"HR Taylor","year":"2006","unstructured":"Taylor HR, Pezzullo ML, Keeffe JE. The economic impact and cost of visual impairment in Australia. Br J Ophthalmol. 2006;90:272\u20135.","journal-title":"Br J Ophthalmol"},{"key":"6098_CR41","unstructured":"Monthly comparative price levels. Retrieved from https:\/\/stats.oecd.org\/Index.aspx?DataSetCode=CPL, 28 Aug 2018, 2018. at https:\/\/stats.oecd.org\/Index.aspx?DataSetCode=CPL.)"},{"key":"6098_CR42","volume-title":"Personal consumption expenditures: net health insurance: medical care and hospitalization (chain-type price index) [DMINRG3A086NBEA]","author":"U.S. Bureau of Economic Analysis","year":"2018","unstructured":"U.S. Bureau of Economic Analysis. Personal consumption expenditures: net health insurance: medical care and hospitalization (chain-type price index) [DMINRG3A086NBEA]. 2018."},{"key":"6098_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/1475-6773.12612","volume":"53","author":"A Dunn","year":"2018","unstructured":"Dunn A, Grosse SD, Zuvekas SH. Adjusting health expenditures for inflation: a review of measures for health services research in the United States. Health Serv Res. 2018;53:175\u201396.","journal-title":"Health Serv Res"},{"key":"6098_CR44","unstructured":"Health economic analysis at PHARMAC. New Zealand Government, 2020. at https:\/\/www.pharmac.govt.nz\/medicines\/how-medicines-are-funded\/economic-analysis\/pfpa\/2-health-economic-analysis-at-pharmac\/.)"},{"key":"6098_CR45","unstructured":"National Institute for Health and Care Excellence Guide to the methods of technology appraisal 2013. National Institute for Health and Care Excellence; 2013."},{"key":"6098_CR46","doi-asserted-by":"crossref","unstructured":"Kwon J, Kim SW, Ungar WJ, Tsiplova K, Madan J, Petrou S. A systematic review and meta-analysis of childhood health utilities. Med Decis Mak. 2018;38(3):277\u2013305.","DOI":"10.1177\/0272989X17732990"},{"key":"6098_CR47","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/0272989X08327398","volume":"29","author":"S Petrou","year":"2009","unstructured":"Petrou S, Kupek E. Estimating preference-based health utilities index mark 3 utility scores for childhood conditions in England and Scotland. Med Decis Mak. 2009;29:291\u2013303.","journal-title":"Med Decis Mak"},{"key":"6098_CR48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jpeds.2009.01.040","volume":"155","author":"AE Carroll","year":"2009","unstructured":"Carroll AE, Downs SM. Improving decision analyses: parent preferences (utility values) for pediatric health outcomes. J Pediatr. 2009;155:21\u20135 e5.","journal-title":"J Pediatr"},{"key":"6098_CR49","doi-asserted-by":"crossref","unstructured":"Hegarty JE, Harding JE, Gamble GD, Crowther CA, Edlin R, Alsweiler JM. Prophylactic oral dextrose gel for newborn babies at risk of neonatal hypoglycaemia: a randomised controlled dose-finding trial (the pre-hPOD study). PLoS Med. 2016;13.","DOI":"10.1371\/journal.pmed.1002155"},{"key":"6098_CR50","unstructured":"Statistics NZ Tatauranga Aotearoa. Births and deaths. New Zealand2019."},{"key":"6098_CR51","unstructured":"National Center for Health Statistics. Births: final data for 2017. United States: Retrieved from https:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr67\/nvsr67_08-508.pdf, 01 Feb; 2018."},{"key":"6098_CR52","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000492859","volume":"115","author":"R Shah","year":"2018","unstructured":"Shah R, Harding J, Brown J, McKinlay C. Neonatal glycaemia and neurodevelopmental outcomes: a systematic review and meta-analysis. Neonatology. 2018;115:116\u201326.","journal-title":"Neonatology"},{"key":"6098_CR53","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1586\/erp.10.24","volume":"10","author":"SD Grosse","year":"2010","unstructured":"Grosse SD, Prosser LA, Asakawa K, Feeny D. QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique. Expert Rev Pharmacoecon Outcomes Res. 2010;10:293\u2013308.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"6098_CR54","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/hec.775","volume":"12","author":"S Petrou","year":"2003","unstructured":"Petrou S. Methodological issues raised by preference-based approaches to measuring the health status of children. Health Econ. 2003;12:697\u2013702.","journal-title":"Health Econ"},{"key":"6098_CR55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0022-3476(94)70252-7","volume":"124","author":"PW Newacheck","year":"1994","unstructured":"Newacheck PW, Stoddard JJ. Prevalence and impact of multiple childhood chronic illnesses. J Pediatr. 1994;124:40\u20138.","journal-title":"J Pediatr"},{"key":"6098_CR56","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/hec.1373","volume":"18","author":"A Basu","year":"2009","unstructured":"Basu A, Dale W, Elstein A, Meltzer D. A linear index for predicting joint health-states utilities from single health-states utilities. Health Econ. 2009;18:403\u201319.","journal-title":"Health Econ"},{"key":"6098_CR57","doi-asserted-by":"publisher","first-page":"E29","DOI":"10.1177\/0272989X10374508","volume":"30","author":"H Bo","year":"2010","unstructured":"Bo H, Fu AZ. Predicting utility for joint health states: a general framework and a new nonparametric estimator. Med Decis Mak. 2010;30:E29\u201339.","journal-title":"Med Decis Mak"},{"key":"6098_CR58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1478-7954-4-13","volume":"4","author":"W Flanagan","year":"2006","unstructured":"Flanagan W, McIntosh CN, Le Petit C, Berthelot J-M. Deriving utility scores for co-morbid conditions: a test of the multiplicative model for combining individual condition scores. Popul Health Metrics. 2006;4:13.","journal-title":"Popul Health Metrics"},{"key":"6098_CR59","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/MLR.0b013e3181791a9c","volume":"46","author":"AZ Fu","year":"2008","unstructured":"Fu AZ, Kattan MW. Utilities should not be multiplied: evidence from the preference-based scores in the United States. Med Care. 2008;46:984\u201390.","journal-title":"Med Care"},{"key":"6098_CR60","doi-asserted-by":"publisher","first-page":"e842","DOI":"10.1542\/peds.2014-2431","volume":"135","author":"J Quach","year":"2015","unstructured":"Quach J, Jansen PW, Mensah FK, Wake M. Trajectories and outcomes among children with special health care needs. Pediatrics. 2015;135:e842\u201350.","journal-title":"Pediatrics"},{"key":"6098_CR61","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1542\/peds.100.2.197","volume":"100","author":"HT Ireys","year":"1997","unstructured":"Ireys HT, Anderson GF, Shaffer TJ, Neff JM. Expenditures for care of children with chronic illnesses enrolled in the Washington state Medicaid program, fiscal year 1993. Pediatrics. 1997;100:197\u2013204.","journal-title":"Pediatrics"},{"issue":"Pt 5","key":"6098_CR62","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1046\/j.1365-2788.2000.00280.x","volume":"44","author":"K Patja","year":"2000","unstructured":"Patja K, Iivanainen M, Vesala H, Oksanen H, Ruoppila I. Life expectancy of people with intellectual disability: a 35-year follow-up study. J Intellect Disabil Res. 2000;44(Pt 5):591\u20139.","journal-title":"J Intellect Disabil Res"},{"issue":"Suppl 11","key":"6098_CR63","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1528-1167.2005.00403.x","volume":"46","author":"L Forsgren","year":"2005","unstructured":"Forsgren L, Hauser WA, Olafsson E, Sander JW, Sillanpaa M, Tomson T. Mortality of epilepsy in developed countries: a review. Epilepsia. 2005;46(Suppl 11):18\u201327.","journal-title":"Epilepsia"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-021-06098-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-021-06098-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-021-06098-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T23:28:22Z","timestamp":1671060502000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-021-06098-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6098"],"URL":"https:\/\/doi.org\/10.1186\/s12913-021-06098-9","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]},"assertion":[{"value":"7 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Author Richard Edlin is an editorial board member. The authors declare that they have no other competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}